Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04452591
Title Study of CG0070 Given in Patients With Non-Muscular Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin (BOND-003)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors CG Oncology, Inc.

urinary bladder cancer


CG0070 + Dodecyl Maltoside

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.